By Justin Yamashita, MSc. Benchtop, site, CRO: three levels of basic and clinical research, explained without spin.
What this is
A Black Box Warning is the strongest alert the FDA can put on a drug. We borrow the name on purpose. Every Monday we put one villain, one tactic, in the black box, so you can learn how to spot the misinformation and be a part of preventing it from spreading further. This newsletter isn’t about the actor, but it is about the act. We name the tricks that are quietly working on you and your loved ones, and hand you the tools to see it.
This week's timing isn't a coincidence. An FDA advisory committee just spent two days deciding whether a series of peptides belong on a legal prescription list. Tuesday, we take you inside that room. Wednesday, we take the whole claim apart. Today, we start with the move, the act, the source of misinformation and confusion.
Forward the warning
If someone you know is about to trust a vial with no label, send them this first.
From the last issue
Last issue, we caught a drug wearing a leaf to sound less strong and safer. This issue, it stops pretending to be a plant at all. Today we open the box on the vial with no label. The one sold "for research use only," injected anyway, and trusted more than the medicine people are scared of. Same fear, turned all the way up.
The Black Box Warning: The Blank Label
THE BLACK BOX WARNING: Cherry Picking and Charisma
You've already met Influencer Ivy. This week we’re seeing some of the Broker’s other actors and acts. Meet Cherry the Picker, and watch how the Ivy and Cherry split the job.
1. Cherry picks the proof that fit her narrative. She doesn't fabricate anything. She just leaves out most of what's actually in the story. One clinic calls this compound the "wolverine compound." A single unpublished conference abstract becomes "the research." What Cherry leaves out: that abstract's own numbers never clear the bar for a real effect, and nobody has ever established a dose-response relationship for this peptide.
2. Ivy sells the feeling. She takes whatever fragment Cherry hands her and turns it into something you want to be part of. A vial by the bathroom mirror, a caption about feeling "optimized." Fifty million video views and counting. No leaflet in the shot, because there isn't one.
3. Together, they skip the receipt. An approved medicine's receipt is years of trials and a label that reads every risk out loud. Cherry's cherry-picked fragment plus Ivy's charisma add up to something that looks like proof, but it isn't. It's a highlight reel standing in for a dataset. This is what fools the untrained eye, the brain that hasn’t been given the tools. But, you’re here, in the right place, to learn how to spot, to obtain the tools to tackle so you don’t get fooled by part of the story, or Ivy’s vibes. And you can help share it with others too to combat the spread of misinformation and fear.
The Black Box Warning Follow-Up Question
Sam the Skeptic: “So who actually profits here?”
Ivy the Influencer gets enough followers and gets her inbox flooded with requests to use scripted “candid” videos explaining how her life has been changed using this product in exchange for an affiliate link and a commission.
Cherry the Picker gets paid too, not in dollars- rather in attention. The cherry-picked fragment is the one that keeps you watching, so it's the one the algorithm keeps feeding you. Follow the money on both of them: the affiliate code, and the engagement that enables them to hock other products with their ever increasing fear induced following.
Watch for the costume this week
Watch for the blank label this week. Tuesday, we walk into the room where they argued about it. Wednesday, we run the whole claim through the Toolkit. Thursday, the full evidence file. Friday, the verdict.
Want Thursday and Friday too?
The Informed (Thursday) and The Verdict (Friday) do not come automatically. You turn them on yourself. It takes a moment. Opt-in Instructions
Try it yourself: see if you’d have caught this week's costume on your own.
The Skeptic Type quiz sorts you into your pattern in about two minutes: openlabelmedia.com/skeptic-type.
Got Skepticism? runs any claim through the same one-question move Sam just used.
Stay in the Room shows you how to disagree without a fight so that you can talk to people about these difficult topics.
The quiz and both games play in your browser at openlabelmedia.com, and I would love to see your results on social.
For educational purposes only. Nothing in this newsletter is medical advice. Talk to your doctor before making any health decision.
References
[1] Box Warning. StatPearls, National Library of Medicine (NIH). ncbi.nlm.nih.gov/books/NBK538521
[2] FDA Briefing Document for BPC-157-Related Bulk Drug Substances. Pharmacy Compounding Advisory Committee. July 23-24, 2026. fda.gov/media/193343/download
[3] Pharmacy Compounding Advisory Committee meeting page, July 23-24, 2026. fda.gov/advisory-committees
[4] Salzman, S. and Kekatos, M. FDA advisory committee votes to add popular peptide BPC-157 to drug compounding list. ABC News. July 23, 2026.
Instagram: instagram.com/roottorx | Facebook Lab: facebook.com/groups/theroottorxlab | TikTok: tiktok.com/@root.to.rx | YouTube: youtube.com/@roottorx | Threads: threads.com/@roottorx | Subscribe: RootToRx.com
Disclosure: Root to Rx is published independently by Open Label Media LLC. Views expressed are personal views of Justin Yamashita and do not represent his employer or any affiliated organization. No employer resources or proprietary information are used. Every claim is sourced from publicly available materials.
Root to Rx | 228 Park Ave S, #29976, New York, New York 10003, United States